
© Sarah Silbiger/Getty Images
In a rather shocking turn of events, the U.S. Food and Drug Administration sneaked in a "Future Framework"
1 scheme
that will allow Pfizer and Moderna to reformulate and release updated COVID shots without conducting any additional human clinical trials, other than what's already been done.2,3,4FDA Rewrites the Rules on the FlyA vote on the Framework was scheduled to be taken June 28, 2022, by the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), but while the VRBPAC approved (19-2) a bivalent COVID shot for fall 2022,
5 the expected voting on the Framework, specifically, didn't seem to take place — only it DID.
As it turns out, we've been bamboozled yet again by an agency that keeps rewriting the rules on the fly. Toby Rogers, Ph.D. — a political economist whose research focus is on regulatory capture and Big Pharma corruption
6 — explains how they sneaked this one by us:
7
Comment: